SARS-CoV-2 testing and clinical outcomes in a Texas tertiary care center labor and delivery unit.

Autor:	Woodard T; Kirksville College of Osteopathic Medicine, A. T. Still University of Health Sciences, Kirksville, Missouri., Anderson L; Kirksville College of Osteopathic Medicine, A. T. Still University of Health Sciences, Kirksville, Missouri., Ehrig J; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Baylor Scott & White Medical Center - Temple, Temple, Texas., Shaver C; Office of Biostatistics, Baylor Scott & White Research Institute, Temple, Texas., Hofkamp M; Department of Anesthesiology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Jazyk:	angličtina
Zdroj:	Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2021 Jan 11; Vol. 34 (2), pp. 229-231. Date of Electronic Publication: 2021 Jan 11.
DOI:	10.1080/08998280.2020.1866477
Abstrakt:	Our hospital adopted universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing for labor and delivery patients in April 2020. The primary aim of this study was to determine the number of subjects from April 1, 2020, to July 31, 2020, who had laboratory-confirmed SARS-CoV-2 infection, and the secondary aims were to report demographic and clinical data for subjects with and without SARS-CoV-2 infection and the time from SARS-CoV-2 test collection to result for tests administered in the hospital. A total of 898 subjects had either vaginal or cesarean deliveries with a gestational age of >20 weeks during the study period. Of this group, 746 subjects underwent SARS-CoV-2 testing, and 16 had a positive test result. Four of the 16 subjects with laboratory-confirmed SARS-CoV-2 infection had documented symptoms at the time of admission. The difference in cohort size was too large to make a meaningful statistical comparison in demographic and clinical data between those with positive vs negative SARS-CoV-2 test results. The median time from SARS-CoV-2 test collection to result decreased from 239 minutes in April 2020 to 119 minutes in July 2020. Universal SARS-CoV-2 testing revealed a 2.1% positivity rate during our study period. (Copyright © 2021 Baylor University Medical Center.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu